Class
| • | 2. Biological Sciences | [X] |
Subdivision
| • | 200 |
(2)
| | • | 201. Molecular Biology and Biochemistry |
(12)
| | • | 202. Cellular and Developmental Biology |
(8)
| | • | 203. Evolution & Ecology, Systematics, Population Genetics, Paleontology, and Physical Anthropology |
(12)
| | • | 204. Medicine, Surgery, Pathology and Immunology |
(13)
| | • | 205. Microbiology |
(9)
| | • | 206. Physiology, Biophysics, and Pharmacology |
(7)
| | • | 207. Genetics |
(1)
| | • | 208. Plant Sciences |
(6)
| | • | 209. Neurobiology |
(9)
| | • | 210. Behavioral Biology, Psychology, Ethology, and Animal Behavior |
(5)
|
| | 21 | Name: | Dr. Sandra Díaz | | | Institution: | Universidad Nacional de Córdoba, Argentina; Instituto Multidisciplinario de Biología Vegetal, Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina | | | Year Elected: | 2022 | | | Class: | 2. Biological Sciences | | | Subdivision: | 205. Microbiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1961 | | | | | | |
Sandra Díaz is Professor of Ecology at Córdoba National University, senior member of the Argentine National Research Council and Visiting Professor at the School of Geography and the Environment, Oxford University. She is interested in plant functional traits and syndromes, their effects on ecosystem properties and their interactions with global change drivers. She constructed the first global quantitative picture of essential functional diversity of vascular plants –the global spectrum of plant form and function. She has advanced theory and practical implementation of the concept of functional diversity and its effects on ecosystem properties and benefits. She combines her ecology studies with interdisciplinary work on how different societies value and reconfigure nature. She founded Núcleo DiverSus on Diversity and Sustainability, and co-founded the Global Communal Plant Trait Initiative TRY. She co-chaired the Global Assessment of the Intergovernmental Platform on Biodiversity and Ecosystem Services. She is a member of the Academies of Sciences of Argentina, USA, France, Norway, Latin America and the Developing World, and Foreign Fellow of the British Royal Society. Her awards include the Margalef Prize in Ecology (2017), the Gunnerus Award in Sustainability Science (2019), the Kew International Medal (2020) and the BBVA Frontiers of Knowledge in Ecology and Conservation Award (2021). | |
| 22 | Name: | Dr. André A. Lwoff | | | Year Elected: | 1967 | | | Class: | 2. Biological Sciences | | | Subdivision: | 201. Molecular Biology and Biochemistry | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1902 | | | Death Date: | 9/30/94 | | | | |
| 23 | Name: | Dr. Andrew Balmford | | | Institution: | University of Cambridge | | | Year Elected: | 2024 | | | Class: | 2. Biological Sciences | | | Subdivision: | 205. Microbiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1963 | | | | | | |
Andrew Balmford is Professor of Conservation Science in the Department of Zoology, University of Cambridge, where his research focuses on how to reconcile biodiversity conservation with meeting human food needs and other land-demanding activities, and on the costs and benefits of retaining intact ecosystems. He collaborates closely with conservation practitioners and with colleagues in other disciplines including economics, agriculture and psychology. Andrew helped establish the Student Conference on Conservation Science, the Cambridge Conservation Forum, Earth Optimism, and most recently the Cambridge Centre for Carbon Credits. In his book ‘Wild Hope’ - which has since inspired a TV series - he argues that cautious, evidence-based optimism is vital in tackling environmental challenges. | |
| 24 | Name: | Dr. Jean-Michel Dubernard | | | Institution: | Université Claude Bernard Lyon 1; E. Herriot Hospital; French National Authority for Health (Haute Autorité de Santé) | | | Year Elected: | 2010 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1941 | | | Death Date: | July 10, 2021 | | | | | | |
Jean-Michel Dubernard is a surgeon in the Department of Urology and Transplantation Surgery at E. Herriot Hospital in Lyon. He is also a former Deputy Mayor of Lyon and a former member of the French National Assembly.
Dr. Dubernard attended medical school in Lyon. He then served as a Research Fellow with Joseph Murray at the Peter Bent Brigham Hospital (1965-1967) in Boston. Dr. Dubernard received his Docteur en Medecine from Lyon University in 1967. He subsequently received his Docteur en Biologie Humaine in Transplantation Immunology in 1971. As a surgeon, Dr. Dubernard is an important pioneer. His research interests continue to lie in experimental surgery, clinical transplantation (especially renal transplantation in children), medical technology, general urology, renal and pancreatic lithotripsy, endoscopy of the upper urinary tract investigations of male impotence, vascular surgery and microsurgery. In 1998 he led the international team that performed the world’s first modern hand-forearm transplant and in 2005 Dr. Dubernard's team performed the world’s first partial face transplant.
Dr. Dubernard is the President of the International Hand and Composite Tissue Allografts, as well as the Founder and President of the European College of Transplantation. Since 1980 he has been a member of the European Society for Organ Transplantation’s Founding Council. Dr. Dubernard was President of the International Microsurgical Society (1984-1986), President of the Société Française de Transplantation (1991-1994), and President of the International Pancreatic and Islet Transplant Association (1996-1997). His work has more than 400 scientific references in the form of articles, chapters of books, books, and films. In 2008 Dr. Dubernard received the Medawar Prize, the highest award of the International Transplantation Society. | |
| 25 | Name: | Rene Jules Dubos | | | Year Elected: | 1954 | | | Class: | 2. Biological Sciences | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1901 | | | Death Date: | 2/20/82 | | | | |
| 26 | Name: | Dr. Christian de Duve | | | Institution: | Rockefeller University & Catholic University, Louvain | | | Year Elected: | 1991 | | | Class: | 2. Biological Sciences | | | Subdivision: | 202. Cellular and Developmental Biology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1917 | | | Death Date: | May 4, 2013 | | | | | | |
Belgian biochemist Christian de Duve had been Emeritus Professor at both Catholic University, Louvain (since 1985) and Rockefeller University (since 1988) prior to his death on May 4, 2013 at the age of 95 at his home in Nethen, Belgium. He received his Ph.D. from the University of Louvain in 1945, training under Albert Claude and Hugo Theorell. A specialist in subcellular biochemistry and cell biology, Dr. de Duve was credited with discovering peroxisomes, a cell organelle, and his unique improvements on zonal centrifugation in the early 1960s led to the identification of the lysosomal fractions and its most important function in health and disease. His work on cell fractionalization has also provided a great deal of insight into the function of cell structures. For his work describing the structure and function of organelles in biological cells, Dr. de Duve, together with Albert Claude and George E. Palade, was awarded the Nobel Prize for Physiology or Medicine in 1974. He is also the recipient of the Heineken Medal (1973) and a member of the National Academy of Sciences (1975). He was elected a member of the American Philosophical Society in 1991. | |
| 27 | Name: | Professor Raymond A. Dwek | | | Institution: | Institute of Biology; Glycobiology Institute, University of Oxford | | | Year Elected: | 2006 | | | Class: | 2. Biological Sciences | | | Subdivision: | 201. Molecular Biology and Biochemistry | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1941 | | | | | | |
Raymond Dwek was born on November 10, 1941 in Manchester, England and studied at Manchester University, where he obtained his B.Sc. degree in 1963 and his M.Sc. degree in 1964. Dr. Dwek received his D.Phil. degree from Lincoln College, Oxford. He was awarded a D.Sc from Oxford University in 1985. Raymond Dwek's early research work (1963-73) was concerned with novel applications of Nuclear Magnetic Resonance to Physical, Inorganic and Biochemistry summarised in his book in 1973. He pioneered the application of magnetic resonance to antibody molecules. His subsequent work on the antibody molecule focused on the structural and functional roles of the conserved carbohydrates. This led to the concept that glycoproteins exist in many glycosylated variants, or glycoforms. In 1988, in a seminal review, he introduced the term 'Glycobiology' which entered the Oxford English Dictionary in 1991. Early in his career, Dr. Dwek pioneered industrial-academic partnerships. In 1982, he secured a grant with Monsanto Company, the first major interaction Oxford University had with an industrial company in its 800 year history. As a result, Dr. Dwek and his colleagues were able to develop technology for studying sugar attached to proteins. This led to opportunities for drug discovery which eventually led to worldwide approval of a drug for Gaucher Disease and new approaches for anti-viral agents for the treatment of chronic hepatitis B and C viral infection and HIV. In 1988, he founded Oxford GlycoSciences, Oxford University's first ever spin-off company, using the technology emerging from his laboratory. In 1991 he founded the Glycobiology Institute at Oxford University of which he became Director. He also was Head of the Department of Biochemistry at Oxford University from 2000-2007 and Institute Professor at the Scripps Research Institute in 2008. He was elected in 2008 to a three year term as President of the Institute of Biology. Dr. Dwek has served on a number of institutional and corporate boards including United Therapeutics, USA. His scientific positions include Personal Special Advisor on Biotechnology to the President of Ben Gurion University, Israel where he has been involved in helping to build a National Institute of Biotechnology in the Negev. In 2007 he was appointed Chair of Technology and Society in the John W. Kluge Center at the Library of Congress. His honors and awards include the Seventh Wellcome Trust Award for Research in Biochemistry Related to Medicine in 1994, the First Scientific Leadership Award from the Hepatitis B Foundation in 1997, the Institute of Biology's Huxley Medal in 2007 and the Romanian Order of Merit with rank of commander in 2000 for his major contribution to Romanian-British co-operation in biochemistry and molecular biology. He has received honorary doctorates from The Katholieke Universiteit, Leuven, Belgium and Ben Gurion University in Beer-Sheva, Israel, The Scripps Institute, La Jolla, USA and Cluj University, Romania. He is an Honorary Fellow of Lincoln College, Oxford, and of the Royal Institute of Physicians, London. Dr. Dwek was elected a Fellow of the Royal Society in 1998 for his "fundamental work in glycobiology, [and] for technical development and research allowing knowledge of oligosaccharides to be placed beside that of proteins and DNA." He is a Fellow of EMBO (The European Molecular Biology Organisation). The author of three books, over 500 scientific articles, and a large number of editorials for both scientific and general audiences, Dr. Dwek is a co-inventor on over 70 patents. | |
| 28 | Name: | Sir John C. Eccles | | | Institution: | State University of New York, Buffalo | | | Year Elected: | 1964 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1903 | | | Death Date: | 5/2/97 | | | | |
| 29 | Name: | Ulf Svante von Euler | | | Year Elected: | 1970 | | | Class: | 2. Biological Sciences | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1905 | | | Death Date: | 3/10/83 | | | | |
| 30 | Name: | Dr. Charles Fleming | | | Year Elected: | 1973 | | | Class: | 2. Biological Sciences | | | Subdivision: | 203. Evolution & Ecology, Systematics, Population Genetics, Paleontology, and Physical Anthropology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1916 | | | Death Date: | 9/11/87 | | | | |
| 31 | Name: | Howard W. Florey | | | Year Elected: | 1963 | | | Class: | 2. Biological Sciences | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1898 | | | Death Date: | 2/23/68 | | | | |
| 32 | Name: | Professor Sir Charles Godfray | | | Institution: | Oxford Martin School, University of Oxford | | | Year Elected: | 2021 | | | Class: | 2. Biological Sciences | | | Subdivision: | 205. Microbiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1958 | | | | | | |
Charles Godfray was an undergraduate at the University of Oxford and received his PhD from Imperial College London in 1983. He held a temporary lectureship at Oxford before joining the faculty at Imperial College in 1987 where he remained until 2006, latterly as Director of the NERC Centre for Population Biology. He then returned to Oxford as Hope Professor in the Department of Zoology, in 2018 taking up a new role in the University as Director of the interdisciplinary Oxford Martin School and Professor of Population Biology. He is a fellow of Balliol College. Charles’ research has been in ecology, evolution and epidemiology, and has involved both theoretical approaches as well as field and laboratory studies, typically using insect systems. Starting from his PhD work he has been interested in the structure of communities and pioneered ways of testing theories in community ecology by the construction of quantitative food webs and then doing manipulation experiments in the field. Most recently his community ecology work has included the effects of symbionts (the insect microbiome). He has worked extensively on insect population dynamics and its application to pest management, especially in the tropics. In evolution he has used a group of insects called parasitic wasps to test broad questions in areas such as sex ratio and life history theory. He has employed game theory to develop evolutionary theories of parent-offspring conflict and of signalling within the family. He is very interested in the science policy interface and has worked extensively on food systems, both academically and in advisory roles for UK Government and other organisations. Charles has received the Scientific Medal and the Frink Medal from the Zoological Society of London, and the Linnaean Medal from the Linnaean Society. He is an Honorary Member or Fellow of the Royal Entomological Society, the British Ecological Society, and the International Academy of Food Science and Technology. He is a Fellow of the Royal Society and a member of Academia Europaea and the American Academy of Arts and Science. He was knighted for contributions to science and science advice to government in 2017. | |
| 33 | Name: | Dr. Jane Goodall | | | Institution: | Jane Goodall Institute | | | Year Elected: | 1988 | | | Class: | 2. Biological Sciences | | | Subdivision: | 205. Microbiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1934 | | | | | | |
Jane Goodall began her landmark study of chimpanzees in Tanzania in June 1960, under the mentorship of anthropologist and paleontologist Dr. Louis Leakey. Her work at the Gombe Stream Chimpanzee Reserve would become the foundation of future primatological research and redefine the relationship between humans and animals. One of Jane's most significant discoveries came in her first year at Gombe, when she saw chimps stripping leaves off stems to make the stems useful for fishing termites out of nearby mounds. This and subsequent observations of Gombe chimps making and using tools would force science to rethink the definition that separated man from other animals: "man the toolmaker." Jane also observed chimps hunting and eating bushpigs and other animals, disproving the widely held belief that chimpanzees were primarily vegetarians. Dr. Goodall defied scientific convention by giving the chimpanzees names instead of numbers, and insisted on the validity of her observations that the chimps had distinct personalities, minds and emotions. She wrote of lasting chimpanzee family bonds. Through the years her work yielded surprising insights such as the discovery that chimpanzees engage in warfare. Dr. Goodall established the Gombe Stream Research Center in 1964. Under the stewardship of Tanzanian field staff and other researchers, it continues Dr. Goodall's work today, making it one of the longest uninterrupted wildlife studies in existence. In 1977, Goodall established the Jane Goodall Institute (JGI), which supports the Gombe work and other research, education and conservation and development programs. These include community-centered conservation efforts in Africa that empower villagers to build sustainable livelihoods while promoting regional conservation goals such as reforestation and an end to the illegal commercial bushmeat trade. JGI's Roots & Shoots program, which supports students from preschool through university in projects that benefit people, animals and the environment, today hosts about 6,000 worldwide groups in more than 87 countries. Dr. Goodall travels an average of 300 days per year, speaking about the threats facing chimpanzees, other environmental crisis, and her reason for hope that human kind will solve the problems it has imposed on the earth. She continually urges her audiences to recognize their personal responsibility and ability to effect change through consumer action, lifestyle change and activism. Her most recent book is Seeds of Hope: Wisdom and Wonder From the World of Plants (2013). In 2016 she was awarded the Krogman Award from the Penn Museum and in 2021 she won the Templeton Prize. | |
| 34 | Name: | Dr. Ragnar Granit | | | Institution: | Karolinska Institutet | | | Year Elected: | 1954 | | | Class: | 2. Biological Sciences | | | Subdivision: | 206. Physiology, Biophysics, and Pharmacology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1900 | | | Death Date: | 3/12/91 | | | | |
| 35 | Name: | Dr. Carl G. Groth | | | Institution: | Karolinska Institute | | | Year Elected: | 2004 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1933 | | | Death Date: | February 16, 2014 | | | | | | |
Carl G. Groth, MD, Phd, Professor Emeritus of Transplantation Surgery, Karolinska Institute, Stockholm, Sweden, graduated from the Karolinska Institute, where he obtained his MD and PhD. Between 1966 and 1972 Groth was assigned to the Department of Surgery at the University of Colorado Medical School, first as an NIH international Post doctoral Fellow and later, as an Associate Professor of Surgery. At this department the first successful human liver transplantation in the world was carried out in 1967 by Dr. Thomas Strazl. Groth was a key member of Strazl's surgical team.
Groth served as the Chairman of the Department of Transplantation Surgery at Huddinge Hospital in Stockholm from 1976 to 1995. He was appointed Professor of Transplantation Surgery at the Karolinska Institute in 1984, from which position he retired in 2000. His life time work focused on clinical kidney, liver and pancreas transplantations. He performed pioneer work in pancreatic transplantation as a means to treat patients with type 1 diabetes, particularly with regard to surgical techniques and the effects of the transplantation in the secondary complications of the disease. He has also led a number of highly important studies in transplant patients, examining the new immunosuppressive agents that became available in the 1990's. He performed some unique studies in xenotranspantation, including a pilot trial which fetal pig islets were transplanted to diabetic patients.
Groth served as a principal investigator on numerous research projects including two major consortium grants (from Novartis Pharma and the Juvenile Diabetes Research Foundation) on pig islet transplantation as a means to treat diabetes.
He edited the fist monograph on pancreatic transplantation in 1988. His work includes approximately 700 scientific articles and some 25 book chapters.
Groth served as President of the Transplantation Society in 2001-2002. He was the founding President of the International Pancreas and Islet Transplant Association and the International Xenotransplantation Association. He was an Honorary Fellow of the Royal College of Surgeons of England, the American Surgical Association, the American Society of Transplant Surgeons and the Swedish Society for Gastroenterology. In 1998 he was awarded the King's Medal for outstanding achievement in transplantation. He has also received the Medawar Prize, the foremost International Award in transplantation (2006) and the American Society of Transplant Surgeons Pioneer Award (2008). In 2005 he became a member of the World Health Organization's expert advisory panel on cell, tissue and organ transplantation. He was elected a member of the American Philosophical Society om 2004.
Carl G. Groth died February 16, 2014, at the age of 80, in Stockholm, Sweden. | |
| 36 | Name: | Dr. Marianne Grunberg-Manago | | | Institution: | Institut de Biologie Physico-Chimique | | | Year Elected: | 1992 | | | Class: | 2. Biological Sciences | | | Subdivision: | 201. Molecular Biology and Biochemistry | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1921 | | | Death Date: | January 4, 2013 | | | | | | |
French biologist Marianne Grunberg-Manago had a profound effect on the development of molecular biology. She discovered polynucleotide phosphorylase, the first enzyme capable of synthesizing macromolecules with nucleic acid-like structures, which was subsequently used to elucidate the genetic code. In extending this work, Dr. Grunberg-Manago contributed to the understanding of the translation of the genetic code in the synthesis of protein, in particular as pertains to the role of initiation factors and the dynamic role of ribosomes. She opened a new field of investigation concerning the mechanisms responsible for the initiation of protein synthesis, eludicating the role of several essential protein factors involved in selection of initiation codons. Not only was her research of international stature, but her activities were international in scope as president of the International Union of Biochemistry, president of the French delegation of the French-Soviet Exchanges, a member of the A.S.I. committee of NATO and a Fogarty scholar at the National Institutes of Health, to name a few. Dr. Grunberg-Manago was the first woman to direct the International Union of Biochemistry and was a member of the French Academy of Sciences, American Academy of Arts & Sciences and the National Academy of Sciences. She was elected a member of the American Philosophical Society in 1992. She had been Emeritus Director of Research at the French National Center for Scientific Research at the time of her death on January 4, 2013, at age 91. | |
| 37 | Name: | Sir John Bertrand Gurdon | | | Institution: | Wellcome & University of Cambridge & Magdalene College, Cambridge | | | Year Elected: | 1983 | | | Class: | 2. Biological Sciences | | | Subdivision: | 202. Cellular and Developmental Biology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1933 | | | | | | |
Professor Sir John Gurdon, FRS was educated at Eton College, where he did Classics, having been advised that he was unsuited for science. Accepted at Christ Church, Oxford on Classics entrance, but switched to Zoology (Head of Department Sir Alister Hardy) for his undergraduate course. His PhD was with Michael Fischberg, on nuclear transplantation in Xenopus. Obtained the first clone of genetically identical adult animals. Demonstrated genetic totipotency of somatic cell nuclei by obtaining sexually mature frogs from the nuclei of intestinal epithelium. Did postdoctoral work at CalTech, on bacteriophage genetics. Returned to Oxford as assistant lecturer in Zoology Department in 1962. Took six-month sabbatical leave in 1965 to work with Donald Brown at the Carnegie Institution of Washington, Baltimore. In 1971, moved to MRC Molecular Biology Laboratory in Cambridge under the Chairmanship of Max Perutz, subsequently becoming Head of Cell Biology Division. In 1983, accepted John Humphrey Plummer Professorship of Cell Biology, vacated by Sir Alan Hodgkin, in University of Cambridge, in Zoology Department (Head of Department Prof Gabriel Horn). Initiated, with Prof R. Laskey, Cancer Research Campaign unit of Molecular Embryology in Zoology Department Cambridge. In 1990 moved to new Wellcome CRC Institute of Cancer and Development Biology in Cambridge. Served, 1990-2001, as Chairman of this Institute, which now accommodates 17 independent groups and a total of about 200 persons. Master of Magdalene College in Cambridge from 1995 to 2002 and from 1995 to 2000 served as Governor (Trustee) of the Wellcome Trust. Main directions in research have been: (I) nuclear transplantation and the reprogramming of somatic nuclei; (II) the use of Xenopus eggs and oocytes for mRNA microinjection, and hence gene overexpression; (III) analysis of signaling in normal development, and the use of signaling factors for the redirection of cell differentiation. Has received various recognitions for his work, including the Lasker Award in 2009 and the Nobel Prize in 2012. Interests: skiing, tennis, horticulture, Lepidoptera. | |
| 38 | Name: | Dr. Jan-Ake Gustafsson | | | Institution: | Karolinska Institute; University of Houston | | | Year Elected: | 2008 | | | Class: | 2. Biological Sciences | | | Subdivision: | 201. Molecular Biology and Biochemistry | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1943 | | | | | | |
Jan-Åke Gustafsson, M.D., Ph.D., has played a pivotal role in discoveries of how nuclear receptors in the cell mediate actions of hormones and nutrients to regulate gene expression. Dr. Gustafsson is Professor of Medical Nutrition and Chairman of the Department of Biosciences and Nutrition, Novum, Karolinska University Hospital at the Karolinska Institutet in Stockholm, Sweden. Dr. Gustafsson first described the three-domain structure of nuclear receptors, defined the function of these domains, and determined how the DNA-binding mechanism mediates nuclear receptor activities in the cell. He also was the first to discover that fatty acids are natural activators of the peroxisome proliferator activated nuclear receptor (PPAR), thus stimulating the investigation of the role of PPARs in lipid metabolism. Furthermore, Dr. Gustafsson discovered a second type of estrogen receptor (ER?) as well as a nuclear receptor that is important in cholesterol metabolism (LXR?). Dr. Gustafsson received his Bachelor of Medicine degree in 1964, his Ph.D. in chemistry in 1968 and his M.D. degree in 1971, all from the Karolinska Institute. He was named a professor of chemistry at the Institute in 1976, and to his current posts in 1979. In 1987, he founded KaroBio AB, a biotechnology company based at the Karolinska Institute, initially supported by pension and government funds. Career/Academic Appointments: 1964 Bachelor of Medicine, Karolinska Institutet, Stockholm 1971 Associate Professor in Chemistry, Karolinska Institutet 1976 Professor of Chemistry, Karolinska Institutet 1978 Professor of Chemistry, University of Gothenburg 1979 Professor of Medical Nutrition and Chairman of the Dept of Medical Nutrition, Huddinge University Hospital, Karolinska Institutet 2006-present Professor of Medical Nutrition and Chairman of the Dept of Biosciences and Nutrition, Karolinska Institutet Among the honors he has received during his career are: The Svedberg Prize in chemistry in 1982, the Fernström Prize of the Karolinska Institute in 1983, the Anders Jahre Prize in 1992, the Gregory Pincus Medal and Award of the Worcester Foundation in 1994, the Söderberg Prize in Medicine in 1998, the European Medal of the British Society for Endocrinology in 2000, the Lorenzini Gold Medal in 2001, the Fred Conrad Koch Award from the Endocrine Society in the U.S. in 2002, the Bristol-Meyers Squibb/Mead Johnson Award for Nutrition Research in 2004, the Geoffrey Harris Prize in 2009, the Award of Merit of the Princess Takamatsu Cancer Research Fund in 2009, the Grand Nordic Fernstrom Prize of the University of Lund in 2009, and the Grand Silver Medal of the Karolinska Institutet in 2011. Dr. Gustafsson was elected to the Swedish Academy of Sciences in 1997, to the Swedish Academy of Engineering Sciences in 1998, became a foreign honorary member of the American Academy of Arts and Sciences in 2000 and a foreign honorary member of the U.S. National Academy of Sciences in 2002. In 2002 he was Chairman of the Nobel Assemly of the Karolinska Institutet. Jan-Åke Gustafsson was elected an international member of the American Philosophical Society in 2008. | |
| 39 | Name: | Dr. William D. Hamilton | | | Institution: | University of Oxford | | | Year Elected: | 1999 | | | Class: | 2. Biological Sciences | | | Subdivision: | 203. Evolution & Ecology, Systematics, Population Genetics, Paleontology, and Physical Anthropology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1936 | | | Death Date: | March 7, 2000 | | | | |
| 40 | Name: | Dr. Harald zur Hausen | | | Institution: | German Cancer Research Center (Deutsches Krebsforschungszentrum) | | | Year Elected: | 1998 | | | Class: | 2. Biological Sciences | | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1936 | | | Death Date: | May 28, 2023 | | | | | | |
Harald zur Hausen is a world renowned virologist who has made pioneering discoveries on viruses that cause human tumors. He made major contributions to our knowledge of the Epstein-Barr virus, the agent involved in Burkitt's lymphoma and nasopharyngeal carcinoma. His most important discovery, for which he was awarded the 2008 Nobel Prize in Medicine, is the causative role of papillomaviruses in human anogenital cancer. His work has far-reaching implications for human health and well-being and provides the basis for antiviral vaccines that could prevent some of the most common human malignancies. As Director of the German Cancer Research Center since 1983, Dr. zur Hausen has had a major influence on the organization, development and support of science. He has turned this institution into a leading center for biological and clinical research. A graduate of the University of Dusseldorf (M.D., 1960), Dr. zur Hausen is a member of the European Molecular Biology Organization (1976); the Heidelberg Academy of Sciences (1986); the German Academy of Natural Sciences (1986); the Academia Europaea (1990); the Polish Academy of Sciences (foreign member) (1991); and the Venezuelan National Academy of Medicine (1993). | |
| |